
FDA to Lead International Effort to Secure the Supply Chain
The agency will lead an international team to create a Supply Chain Security Toolkit of resources to educate the pharmaceutical and healthcare industries on supply chain vulnerabilities.
On July 20, 2017, in an
Regulators from 21 nations, industry stakeholders, and representatives from non-government organizations and academia will be collaborating to develop strategies to secure the medical product supply chain across the world. The toolkit will use a multi-layer approach to prevent, detect, and respond to falsified medicines and products before they reach consumers. It will include materials on good manufacturing, distribution, import/export, and clinical practices; product safety; detection technology; Internet sales; track-and-trace systems; surveillance monitoring; and single points of contact.
“Substandard and falsified drugs are global problems that need global solutions and global collaboration. We cannot solve these challenges alone and we at FDA are continually looking for ways to collaborate and learn from our regulatory counterparts around the world,” Bernstein stated in the blog post.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.